Literature DB >> 15767348

Association of dietary vitamin A, carotenoids, and other antioxidants with the risk of ovarian cancer.

Ko-Hui Tung1, Lynne R Wilkens, Anna H Wu, Katharine McDuffie, Jean H Hankin, Abraham M Y Nomura, Laurence N Kolonel, Marc T Goodman.   

Abstract

UNLABELLED: Antioxidants may protect the ovaries from oxidative damage and reduce the risk of ovarian cancer. Although a few studies have examined the relation of antioxidant intake to the risk of ovarian cancer, the results have been inconclusive. Questions still remain regarding the effects of confounding factors, such as menopause, tobacco smoking, and alcohol drinking, on the association between antioxidants and ovarian cancer development.
OBJECTIVE: To examine the association of the consumption of micronutrients from foods and supplements with the risk of ovarian cancer.
METHODS: A structured questionnaire was administered to 558 histologically confirmed epithelial ovarian cancer cases and 607 population controls from a multiethnic, population-based case-control study conducted between 1993 and 1999 in Hawaii and Los Angeles.
RESULTS: Overall, vitamin A and carotene intakes were modestly associated with a reduced risk of ovarian cancer. Inverse gradients in ovarian cancer risk with increasing dietary intake of vitamin A and beta-carotene were somewhat stronger among women with mucinous histologic types, smokers, and nondrinkers. A significant positive trend in risk associated with increasing beta-cryptoxanthin intake was observed among postmenopausal women, among women with nonmucinous tumors, and among nonsmokers. The intake of other carotenoids and antioxidants, either from foods or supplements, was unrelated to ovarian cancer risk.
CONCLUSION: Our findings suggest that dietary vitamin A and beta-carotene are modestly protective against ovarian cancer, particularly among smokers. Our data suggest a role for retinoic acid signaling pathways in ovarian carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767348     DOI: 10.1158/1055-9965.EPI-04-0550

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study.

Authors:  Anthony J Alberg; Patricia G Moorman; Sydnee Crankshaw; Frances Wang; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Kathleen B Cartmell; Michelle L Cote; Marvella E Ford; Ellen Funkhouser; Linda E Kelemen; Edward S Peters; Ann G Schwartz; Katherine Regan Sterba; Paul Terry; Kristin Wallace; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-08-03       Impact factor: 4.897

2.  Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

Authors:  Ellen L Goode; Kristin L White; Robert A Vierkant; Catherine M Phelan; Julie M Cunningham; Joellen M Schildkraut; Andrew Berchuck; Melissa C Larson; Brooke L Fridley; Janet E Olson; Penelope M Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Thomas A Sellers
Journal:  Mol Carcinog       Date:  2010-12-28       Impact factor: 4.784

3.  A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors.

Authors:  Raheem J Paxton; Celia Garcia-Prieto; Maria Berglund; Mike Hernandez; Richard A Hajek; Beverly Handy; Jubilee Brown; Lovell A Jones
Journal:  Gynecol Oncol       Date:  2011-11-23       Impact factor: 5.482

4.  Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies.

Authors:  Anita Koushik; Molin Wang; Kristin E Anderson; Piet van den Brandt; Tess V Clendenen; A Heather Eliassen; Jo L Freudenheim; Jeanine M Genkinger; Niclas Håkansson; James R Marshall; Marjorie L McCullough; Anthony B Miller; Kim Robien; Thomas E Rohan; Catherine Schairer; Leo J Schouten; Shelley S Tworoger; Ying Wang; Alicja Wolk; Anne Zeleniuch-Jacquotte; Stephanie A Smith-Warner
Journal:  Cancer Causes Control       Date:  2015-07-14       Impact factor: 2.506

5.  Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women.

Authors:  Paul D Terry; Bo Qin; Fabian Camacho; Patricia G Moorman; Anthony J Alberg; Jill S Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Kristin A Guertin; Edward S Peters; Ann G Schwartz; Joellen M Schildkraut; Elisa V Bandera
Journal:  J Nutr       Date:  2017-02-15       Impact factor: 4.798

6.  Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.

Authors:  Lauren C Peres; Elisa V Bandera; Bo Qin; Kristin A Guertin; Nitin Shivappa; James R Hebert; Sarah E Abbott; Anthony J Alberg; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Fabian Camacho; Frances Wang; Joellen M Schildkraut
Journal:  Int J Cancer       Date:  2016-11-14       Impact factor: 7.396

7.  Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.

Authors:  Lilah Khoja; Rachel Palmieri Weber; Penelope M Webb; Susan J Jordan; Aruna Muthukumar; Jenny Chang-Claude; Renée T Fortner; Allan Jensen; Susanne K Kjaer; Harvey Risch; Jennifer Anne Doherty; Holly R Harris; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Andrew Berchuck; Joellen M Schildkraut; Daniel Cramer; Kathryn L Terry; Hoda Anton-Culver; Argyrios Ziogas; Minh Tung Phung; Gillian E Hanley; Anna H Wu; Bhramar Mukherjee; Karen McLean; Kathleen Cho; Malcolm C Pike; Celeste Leigh Pearce; Alice W Lee
Journal:  Gynecol Oncol       Date:  2021-11-12       Impact factor: 5.304

8.  Total and individual antioxidant intake and risk of epithelial ovarian cancer.

Authors:  Dina Gifkins; Sara H Olson; Lisa Paddock; Melony King; Kitaw Demissie; Shou-En Lu; Ah-Ng Tony Kong; Lorna Rodriguez-Rodriguez; Elisa V Bandera
Journal:  BMC Cancer       Date:  2012-06-01       Impact factor: 4.430

9.  A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study.

Authors:  R Thomas; M Williams; H Sharma; A Chaudry; P Bellamy
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-03-11       Impact factor: 5.554

10.  Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.

Authors:  Mahmood Rasool; Arif Malik; Muhammad Abdul Basit Ashraf; Gulshan Parveen; Shazia Iqbal; Irfan Ali; Mahmood Husain Qazi; Muhammad Asif; Kashif Kamran; Asim Iqbal; Saima Iram; Sami Ullah Khan; Mohammad Zahid Mustafa; Ahmad Zaheer; Rozeena Shaikh; Hani Choudhry; Mohammad Sarwar Jamal
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.